Results 101 to 110 of about 652 (170)

Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis. [PDF]

open access: yesClin Pharmacokinet
Fontana M   +11 more
europepmc   +1 more source

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy. [PDF]

open access: yesFuture Cardiol
Gillmore JD   +24 more
europepmc   +1 more source

Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological Factors. [PDF]

open access: yesActa Derm Venereol
Niemeyer I   +7 more
europepmc   +1 more source

Antimicrobial and antibiofilm actions of iridoids: a comprehensive mechanistic review. [PDF]

open access: yesNaunyn Schmiedebergs Arch Pharmacol
Elosaily AH   +9 more
europepmc   +1 more source

Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis. [PDF]

open access: yesJACC CardioOncol
Judge DP   +12 more
europepmc   +1 more source

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy. [PDF]

open access: yesCirc Heart Fail
Testani JM   +15 more
europepmc   +1 more source

Topical Losartan Inhibition of Myofibroblast Generation in Rabbit Corneas With Acute Incisions. [PDF]

open access: yesCornea
Martinez VV   +6 more
europepmc   +1 more source

Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary. [PDF]

open access: yesFuture Cardiol
Fontana M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy